Dr. Chambers is nationally recognized as an academic leader, on the basis of the breadth of her skills, emphasis on
excellence, and advocacy for her programs. She was elected to the Institute of Medicine of the National Academy of
Sciences in 2009. She joins a very small cadre of obstetricians and gynecologists in the nation who have been
similarly honored. She has expertise from very basic through translational research, investigator-initiated clinical
trials, to active clinical care. Her laboratory is devoted to understanding the molecular basis for breast and ovarian
cancer metastases for over 2 decades. She continues to study 3’UTR regulators of gene expression, including RNA
binding proteins and more recently miRNAs. She developed the clinic for women at high risk for breast and ovarian
cancer at the University of Arizona, and her translational research has focused on early detection as well as
identification of biomarkers in the fallopian tube of these high-risk women. Her recent clinical research has
demonstrated the lack of toxicity from a novel up-front intraperitoneal combination therapy of ovarian cancer patients.
This work was highlighted in Clinical Cancer Research. She currently serves as Professor and Bobbi Olson Endowed
Chair in Ovarian Cancer Research, co-Leader of the Cancer Biology Program at the University of Arizona Cancer
Center, and Section Head of Gynecologic Oncology, Vice-Chair of the Department of Obstetrics and Gynecology at the
University of Arizona.
|AJCEOG Copyright © 2013-present. All rights reserved. Published by e-Century Publishing Corporation, Madison, WI 53711, USA